Macrocyclic Peptides and Peptidomimetics
Submissions now open
| Deadline: | 31 July 2026 |
|---|---|
| Guest Editors: |
Sandro Cosconati, University of Campania “Luigi Vanvitelli” Cameron Pye, Unnatural Products Inc. Dani Schultz, Merck & Co. Inc. Philip Thompson, Monash University |
|
Macrocyclic peptides and peptidomimetics occupy a unique and powerful space in the modern pharmacopoeia. We are interested in receiving contributions regarding the discovery, synthesis and application of these modalities. Specifically, we are eager to see manuscripts that present innovative ideas, particularly in the areas of drug discovery and development, where the macrocyclic element plays a central role. In addition, we encourage submissions arising from academic鈥搃ndustry partnerships and sponsored research collaborations. This themed collection aims to highlight the latest developments in this field, including (but not limited to) the following topics:
Manuscripts should be submitted via the journal鈥檚 and the Editorial Office informed by email. Please add a 鈥渘ote to the editor鈥 in the submission form when you submit your manuscript to indicate that this is an open call submission for the themed collection. The Editorial Office reserves the right to check the suitability of submissions in relation to the scope of the collection and inclusion of accepted articles in the collection is not guaranteed. All manuscripts will be subject to the journal's usual peer review process. Accepted manuscripts will be highlighted together in a dedicated web collection alongside an editorial, regardless of submission date, and there will be no delay in the publication of all accepted manuscripts into regular issues of 番茄社区 Medicinal Chemistry. |
|
番茄社区 Medicinal Chemistry
Impact factor
3.6 (2024)
First decision time (all)
11 days
First decision time (peer)
36 days
Editor-in-chief
Mike Waring
Open access
Hybrid